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Background: Membranous nephropathy is one of the most common causes of nephrotic syndrome in adults.
In contrast, acquired factor V inhibitor is a rare bleeding disorder.
Case presentation: A 62-year-old Asian man with a history of cerebral hemorrhage, purpura, eosinophilia and
hyper immunoglobulin E syndrome developed proteinuria. The bleeding disorder was diagnosed with acquired
factor V inhibitors. A renal biopsy revealed that he suffered from membranous nephropathy with glomerular
endothelial damage which is reported to be involved in another factor disorder. After the steroid administration,
the coagulation test and proteinuria were improved.
Conclusions: The presence of factor V inhibitors may have been involved in the development of membranous
nephropathy.Background
Membranous nephropathy (MN) is one of the most
common causes of nephrotic syndrome in adults. MN
occurs as a primary or secondary renal disease. Secondary
MN occurs as a result of autoimmune diseases, infections
and malignancies. In contrast, acquired factor V (FV)
inhibitor is a rare bleeding disorder that is known to be
difficult for physicians to treat because of limited
knowledge and its uncertain relationship with autoimmune
disease. Here we suggest a relationship between MN and
FV inhibitors.Case presentation
A 62-year-old Asian man consulted a doctor because
of asthmatoid wheeze, anarthria, purpura and gait
disturbance. He has no history of hypertension. He
pointed out proteinuria for the first time two months ago
before the consultation. He was diagnosed with a cerebral
hemorrhage following a computerized tomography scan
(Figure 1). His laboratory findings revealed that his serum
creatinine concentration was 0.66 mg/dl, his serum IgE* Correspondence: s-kita@md.okayama-u.ac.jp
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reproduction in any medium, provided the orconcentration was 18230 IU/ml (normal: <170 IU/ml),
and his eosinophil count was 18900/μl. His urinary
analysis revealed 1.61 g/gCr of proteinuria. Coagulation
tests revealed a prolonged activated partial thromboplastin
time at 61.2 seconds and a prothrombin time of 25.5 seconds.
In addition, FV activity alone severely decreased to
4.4% of normal, and an FV inhibitor was present at a titer
of 2.5 BU/ml, suggesting the presence of antibody-mediated
circulating inhibitors specific for FV (Table 1). The patient
was diagnosed with a cerebral hemorrhage, eosinophilia,
hyper IgE syndrome and acquired FV inhibitors. Steroid
therapy with prednisolone (1 mg/kg) for the treatment of
purpura and acquired FV inhibitors was administered.
Treatment with steroid led to the improvement of his
clinical symptoms including purpura, normalization of the
coagulation tests, and disappearance of eosinophilia. To
confirm the diagnosis of proteinuria, we performed a
renal biopsy. Fine granular depositions were observed
at the subepithelial layer in the glomerulus upon IgG
fluorescent staining (Figure 2). Spike formations were
partially observed at the subepithelial layer upon Periodic
acid-methenamine-silver (PAM) staining (Figure 3). An
impaired lamina rara layer and endothelial cell swelling
and detachment were observed with high-density deposits
at the lamina rara externa upon electron microscopic
analysis (Figure 4, Additional file 1: Figure S1 andtral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Left cerebral hemorrhage (arrow) image on
computerized tomography.
Figure 2 Immunoglobulin G fluorescent staining analysis
revealed that fine granular depositions were observed at
subepithelial layer in glomerulus. (Magnification: 400X).
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patient had developed MN with glomerular endothelial
cell damage. After the administration of steroid therapy,
the proteinuria improved gradually.
Discussion
MN is caused by immune complex localization in the
subepithelial zone of glomerular capillaries. Beck et al.
reported that M-type phospholipase A2 receptor (PLA2R) is
a target antigen with idiopathic MN [1]. The Anti- PLA2R
autoantibodies in serum samples from patients with
idiopathic MN were predominantly of IgG4 subclass,
which is the predominant immunoglobulin subclass
seen in glomerular deposits of patients with MN.
However, the Anti- PLA2R autoantibodies were not
exclusively found in secondary MN. In renal biopsy of
this patient, we could not observe the deposits of
IgG4 subclass (Additional file 3: Figure S3). We couldTable 1 Laboratory analysis data of coagulation time and
coagulation factors
Coagulation time Time (sec)
Prothrombin time 25.5
Activated partial thromboplastin time 61.2





Factor X 93.0not find any causes of secondary MN such as malignancy,
infections or drugs. These results suggested that the MN
in this patient may be involved other immune disorders.
On the other hand, there have been some reports
of acquired factor inhibitors complicated by nephrotic
syndrome [2-4]. In addition, there have been reports that
factor VIII-related antigen and tissue plasminogen activatorFigure 3 Periodic acid-methenamine-silver staining analysis
showed that spike formations (arrow) were observed partially at
the subepithelial layer in the glomerulus. (Magnification: 400X).
Figure 4 Electron microscopic analysis demonstrated the
swelling of the endothelial cell (arrow), the damage of lamina
rara layer and electron dense deposit at the subepithelium
(arrow head). (Magnification: 8050X).
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in another factor disorder [5]. There is a possibility
that coagulopathies may be related to the occurrence of
renal disorders with glomerular endothelial cell damages.
In this patient, we observed dense subepithelial deposition
and the detachment of endothelial cells in the glomerulus
upon electron microscopic analysis. It may be suggested
that the characteristic finding of membranous nephropathy
with acquired factor inhibitors is the presence of damage of
the glomerular endothelial cells and lamina rara layer, with
high-density deposits at the subepithelium in the glomeru-
lus. Frigui et al. reported that the eosinophils are associated
with MN [6]. Renal disorders with eosinophils were caused
by several diseases such as drugs, cholesterol embolization,
immunoallergic responses et al. [7]. Giudicelli et al.
described that most secondary renal disorders in hyperphils
are usually due to an immuno-allergic process leading to
deposit of immune complexes in glomeruli. Taken together,
we reported that membranous nephropathy complicated
with factor V inhibitor. The presence of FV inhibitors
should be taken into consideration when patients are diag-
nosed with nephrotic syndrome and MN by renal biopsy
because there is some possibility that the FV inhibitors can
lead to serious bleeding complications.Conclusions
We reported a case of membranous nephropathy with
acquired factor V inhibitor. The renal pathology revealed
the presence of damage of the glomerular endothelial
cells and lamina rara layer, with high-density deposits at
the subepithelium in the glomerulus. It is important
that membranous nephropathy may be complicated with
acquired factor V inhibitor if the pathology is observed.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-chief of this journal.Additional files
Additional file 1: Figure S1. Electron microscopic analysis
demonstrating the detachment of endothelial cells (arrowhead), damage
to the lamina rara layer and electron-dense deposits at the subepithelium
(arrow). (Magnification: 8050X).
Additional file 2: Figure S2. Electron microscopic analysis
demonstrating the electrondense deposits at the subepithelium (arrow).
(Magnification: 6900X).
Additional file 3: Figure S3. Immunohistochemistry analysis
demonstrating not for the immunoglobulin G4 deposits but for
immunoglobulin G deposits in the glomeruli of the patient. deposits at
the subepithelium (arrow). (Magnification: 400X).Competing interests
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